OxySure Systems, Inc. (OXYS) Provides Progress Update on CE Marking
OxySure Systems, a medical technology company that has pioneered an FDA-approved solution to produce medically pure oxygen from dry, inert powders for emergency/short duration use, this morning gave investors a progress report on the CE Marking of its flagship product, the OxySure Model 615. The company received notice earlier this month of an opinion rendered by the Medicines and Healthcare products Regulatory Authority (MHRA) in the United Kingdom related to the classification of the OxySure Model 615 as a medical device. An opinion of this nature by a competent authority is a key step in the CE Marking process. "We…